Back to search

Article

Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: A retrospective study

2025-01-06

Abstract excerpt

<title>Abstract</title> <p>Purpose This study evaluated pharmacogenomic (PGx) testing in children and adolescents with autism spectrum disorder (ASD). ASD frequently presents with co-occurring depression and anxiety. This complex phenotype often results in psychotropic medication polypharmacy. Incorporating PGx testing into the medical work-up may reduce polypharmacy and improve quality of life with symptom redu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9ce25901-ccc2-5564-9688-ad872600982e
DOI
10.21203/rs.3.rs-5753717/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: A retrospective studyDOI 10.21203/rs.3.rs-5753717/v1
Select a neighboring publication to make it the new centre.